Content area
Full text
www.buysellsignals.com
Theravance Biopharma, Inc.'s (NASDAQ: TBPH $8.52) stock price slipped further on Tuesday, sliding an additional 5.0c (0.6%) to close at $8.52.
This brought its 4-day fall to 2.5%; compared with the NASDAQ-100 Index which rose 197.0 points (1.1%) in the four days for a relative price change of -3.6%.
Cumulative volume in the 4 days was 0.5 times the average 4-day volume of 490,428 shares. There were 202,945 shares worth $1.7 million traded today.
Theravance Biopharma, Inc. is the NASDAQ's 13th largest Pharmaceuticals company by market cap.
THERAVANCE BIOPHARMA (TBPH) Stock Dashboard [traded in US Dollars, USD] End-of-Day Tue, Mar 12
http://www.theravance.com
| EPS (FY2023) | ($1.0) | Market Cap | $424 million |
| Shares Outstanding | 49,800,000 | Exchange | NASDAQ [Nasdaq] |
| Last | $8.52 | % of shares outstanding | 65.7% |
| Institutional Ownership | 43,852,537 | Sector | Pharmaceuticals [of 57 stocks] |
| Today's Volume | 202,945 | Today's VI* | 0.4 |
| Ave Daily Volume | 490,428 shares | PV$1000 (1 yr) | $831 |
| 52-Week Price Range | 8.21 - 12.03 |
A year ago the Theravance Biopharma share price was $10.25. $1,000 would have bought 97.6 Theravance Biopharma share on that day. Those 97.6 Shares would be worth $831 at today's share price of $8.52. PV$1000= $831.
Price Volume Snapshot past 3 months (USD)
| Past month to | High | Low | VWAP | Volume Index * |
| 12 Mar 2024 | 10.1 | 8.2 | 8.9 | 0.6 |
| 12 Feb 2024 | 10.1 | 8.2 | 9.2 | 0.6 |
| 12 Jan 2024 | 11.7 | 9.7 | 10.8 | 1.0 |
[*Volume Index of 0.6 means volume for the month was 0.6 times its 12-month average]
[VWAP is defined as the Volume Weighted Average Price]
INDEX
SECTION 1 RECENT NEWS AND RESEARCH
SECTION 2 INSTITUTIONAL OWNERSHIP UPDATED AFTER LAST SEC FILING Q4/2023 REPORTED ON FEB 17
SECTION 3 TODAY'S BEARISH SIGNALS
SECTION 4 ONGOING BEARISH PARAMETERS
SECTION 5 TODAY'S BULLISH SIGNALS
SECTION 6 ONGOING BULLISH PARAMETERS
SECTION 7 CORPORATE PROFILE
SECTION 8 FINANCIALS H1/2023
SECTION 9 TOP MANAGEMENT
Read more...
http://www.buysellsignals.net/BuySellSignals/report/Usnasdaq/Stock/Daily/short//Html/3796_DSR_SR_V2_Annexure.html
APPENDIX I DATA & ARCHIVE DOWNLOAD CENTER
APPENDIX II STOCK IDENTIFIERS
GLOSSARY
SECTION 1 RECENT NEWS AND RESEARCH
Financial News
Annual Report (FY 2023):
Release Date: March 04, 2024
FY2023 Annual Report: Theravance Biopharma Revenue up 12%
Theravance Biopharma (NASDAQ:TBPH) reported total revenue for the year-ended 31 December 2023 [FY2023] of $57.4m, up 12% from $51.3m in the previous year [FY2022].
Annual growth in Revenue
| Year-ended | 31 December [FY/2023] | 31... |